C59H86N2O19
Neat
1127.35
Spa-S-160; SN 654; SN-654; NSC-760091; Methyl Partricin; RefChem:389112; SPAS 160; DTXSID1045900; SPA S 160; A01AB16; D01AA06; G01AA09; G04CX03; 11121-32-7; B7FBW3Y74G; Ipertrofan; Mepartricin; Mepartricina; Mepartricine; Mepartricinum
methyl (19E, 21E, 23E, 25E, 27E, 29E, 31E)-33-[(2R, 3S, 4S, 5S, 6R)-4-amino-3, 5-dihydroxy-6-methyloxan-2-yl]oxy-17-[7-(4-aminophenyl)-5-hydroxy-7-oxoheptan-2-yl]-1, 3, 5, 7, 9, 13, 37-heptahydroxy-18-methyl-11, 15-dioxo-16, 39-dioxabicyclo[33.3.1]nonatriaconta-19, 21, 23, 25, 27, 29, 31-heptaene-36-carboxylate;methyl (19E, 21E, 23E, 25E, 27E, 29E, 31E)-33-[(2R, 3S, 4S, 5S, 6R)-4-amino-3, 5-dihydroxy-6-methyloxan-2-yl]oxy-1, 3, 5, 7, 9, 13, 37-heptahydroxy-17-[5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl]-18-methyl-11, 15-dioxo-16, 39-dioxabicyclo[33.3.1]nonatriaconta-19, 21, 23, 25, 27, 29 and 31-heptaene-36-carboxylate
InChI=1S/C60H88N2O19.C59H86N2O19/c1-36-18-16-14-12-10-8-6-7-9-11-13-15-17-19-48(79-59-56(74)54(61)55(73)38(3)78-59)33-51-53(58(75)77-5)50(71)35-60(76,81-51)34-47(69)30-45(67)28-43(65)26-42(64)27-44(66)29-46(68)32-52(72)80-57(36)37(2)20-25-41(63)31-49(70)39-21-23-40(62-4)24-22-39;1-35-17-15-13-11-9-7-5-6-8-10-12-14-16-18-47(78-58-55(73)53(61)54(72)37(3)77-58)32-50-52(57(74)76-4)49(70)34-59(75,80-50)33-46(68)29-44(66)27-42(64)25-41(63)26-43(65)28-45(67)31-51(71)79-56(35)36(2)19-24-40(62)30-48(69)38-20-22-39(60)23-21-38/h6-19,21-24,36-38,41-43,45-48,50-51,53-57,59,62-65,67-69,71,73-74,76H,20,25-35,61H2,1-5H3;5-18,20-23,35-37,40-42,44-47,49-50,52-56,58,62-64,66-68,70,72-73,75H,19,24-34,60-61H2,1-4H3/b7-6+,10-8+,11-9+,14-12+,15-13+,18-16+,19-17+;6-5+,9-7+,10-8+,13-11+,14-12+,17-15+,18-16+/t36?,37?,38-,41?,42?,43?,45?,46?,47?,48?,50?,51?,53?,54+,55-,56+,57?,59+,60?;35?,36?,37-,40?,41?,42?,44?,45?,46?,47?,49?,50?,52?,53+,54-,55+,56?,58+,59?/m11/s1